Saturday 17 October 2026 Export MRVI’s income statement to Excel — free account

Maravai LifeSciences Holdings, Inc.

Maravai LifeSciences Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $185.7 million, down 28.3% from fiscal 2024. In the quarter to June 2026, revenue grew 8.53%, EPS grew 70.4%, free cash flow grew 127.6% and total debt fell 45.6%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

6.79 0.28 −3.96%

Follow MRVI

Alert me

Market cap: $1.8B
P/E: 0.0×
Fwd P/E: −16.2×
Dividend yield: —
F-score: 2/9
Altman Z: 0.44
Beneish M: −3.30
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	0.00	0.00	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	4.42	2.02	2.53	2.16
P/FCF ratio Full definition →	0.00	0.00	0.00	0.00
P/Operating CF Full definition →	231.34	47.82	(20.61)	(27.41)
P/B ratio Full definition →	2.60	1.12	1.26	0.96
Price to Tangible BV Full definition →	10.52	4.37	5.11	3.56
EV/Sales Full definition →	4.93	2.54	3.09	2.57
EV/EBITDA Full definition →	0.00	0.00	0.00	0.00
EV/Operating CF Full definition →	(40.78)	(13.14)	(9.97)	(10.01)
EV/FCF Full definition →	(28.74)	(9.87)	(8.12)	(7.46)
Quick Ratio Full definition →	2.63	4.68	5.40	4.32
Current Ratio Full definition →	4.05	5.91	6.60	5.29
Net Debt/EBITDA Full definition →	(63.38)	9.70	(1.21)	4.29
Debt/Assets Full definition →	29.27%	37.98%	41.78%	38.06%
Debt/Equity Full definition →	0.50	0.73	0.86	0.75
Asset Turnover Full definition →	0.28	0.24	0.21	0.18
Operating CF/Net income Full definition →	(0.32)	(2.32)	0.64	0.59
Capex/Depreciation Full definition →	(0.03)	(0.34)	0.08	(0.06)
Interest Coverage Full definition →	(3.14)	(0.38)	(8.97)	(6.00)
Research and Development Expense of Revenue Full definition →	7.20%	5.91%	7.60%	9.23%
Selling, General and Administrative Expense of Revenue Full definition →	62.34%	44.19%	63.05%	85.03%
Intangible Assets out of Total Assets Full definition →	0.44	0.38	0.36	0.37
Share Based Compensation of Revenue Full definition →	19.84%	10.24%	7.87%	21.75%
Graham Net Nets Full definition →	(0.10)	(0.22)	(0.22)	(0.22)
Graham Number Full definition →	0.00	0.00	0.00	0.00
Earnings Yield Full definition →	(8.33%)	(25.09%)	(27.69%)	(29.27%)
Free Cash Flow Yield Full definition →	(3.88%)	(12.69%)	(15.07%)	(15.97%)
Revenue per Share Full definition →	0.35	0.45	0.35	0.29
Operating CF per Share Full definition →	0.03	0.06	(0.16)	(0.10)
Capex per Share Full definition →	0.00	(0.03)	(0.01)	(0.03)
Free Cash Flow per Share Full definition →	0.02	0.03	(0.17)	(0.13)
Cash per Share Full definition →	0.47	1.13	1.50	1.68
Shareholders Equity per Share Full definition →	2.40	2.52	2.58	2.98
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	2.40	2.52	2.58	2.98
Free Cash Flow Full definition →	3.62	4.23	(24.88)	(18.81)
Working Capital Full definition →	117.24	209.11	251.33	264.29
Capital Expenditures Full definition →	(0.37)	(4.44)	(2.11)	(3.66)
Net Current Asset Value Full definition →	(92.50)	(92.40)	(101.61)	(91.46)
EV/EBIT Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.01	0.07	0.04	0.09
Price to Operating Income Full definition →	0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →	29.51	30.95	32.01	25.71
Average Payables Full definition →	9.33	9.03	7.43	8.75
Average Inventory Full definition →	43.95	45.12	45.29	47.87
Average Assets Full definition →	750.36	836.48	889.41	1,063.70
Average Common Equity Full definition →	411.79	449.68	474.96	522.49

Fold the line items

Columns are period end dates

Stockrow Weekly